Risk factors of hepatic veno-occlusive disease and preventing measures after hematopoietic stem cell transplantation

Clinical Focus ›› 2011, Vol. 26 ›› Issue (24): 2126-2129.

Previous Articles Next Articles

Risk factors of hepatic veno-occlusive disease and preventing measures after hematopoietic stem cell transplantation

HAN Li-jie;MA Hong-xia;DONG Xiu-juan;ZHAO Xiao-wu

Online:2011-12-20 Published:2011-12-20

Abstract

CLC Number:

R457.7

HAN Li-jie;MA Hong-xia;DONG Xiu-juan;ZHAO Xiao-wu. Risk factors of hepatic veno-occlusive disease and preventing measures after hematopoietic stem cell transplantation[J]. Clinical Focus, 2011, 26(24): 2126-2129.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2011/V26/I24/2126

[1]	. [J]. CLINICAL FOCUS, 2011, 26(13): 1188-1191.
[2]	ZHONG Qi;ZENG Hui-lan;ZHU Kang-er;ZHANG Tao;CHEN Jie;QIN Yong-liang;HAN Xin-ai. Analysis of risk factors for overall survival in 65 patients after allogeneic peripheral blood stem cell transplantation [J]. CLINICAL FOCUS, 2010, 25(18): 1583-1586.
[3]	. [J]. CLINICAL FOCUS, 2008, 23(4): 292-0.
[4]	LU Chang-qing;HUANG Zhen-wen;DANG Yu-hua;QIU Chung-guang;Guo Pan;WANG Gui-ye. Intracoronary autologous bone marrow stem cell transplantation in patients with congestive heart failure due to previous myocardial infarction [J]. CLINICAL FOCUS, 2005, 20(11): 612-614.
[5]	. Autologous bone morrow transplatation for acute leukemia using interleukin-2 in vitro liquid culture purging in combination with interferon-α [J]. CLINICAL FOCUS, 2004, 19(22): 1265-1267.

Risk factors of hepatic veno-occlusive disease and preventing measures after hematopoietic stem cell transplantation

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 5

Recommended Articles

Metrics

Comments